National Health Act 1953 Arrangements made under subparagraph 100(1)(b)(i) Highly Specialised Drugs Program (No. PB 36 of 2007) (Cth)
COMMONWEALTH OF AUSTRALIA
National Health Act 1953
ARRANGEMENTS MADE UNDER SUBPARAGRAPH 100(1)(b)(i)
HIGHLY SPECIALISED DRUGS PROGRAM
No. PB 36 of 2007
I, STEPHEN DELLAR, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing and delegate of the Minister for Health and Ageing, pursuant to subparagraph 100(1)(b)(i) of the National Health Act 1953, hereby make the following Arrangements for the purpose of providing that an adequate supply of special pharmaceutical products will be available to persons who are receiving treatment with highly specialised drugs at private hospitals as non-admitted patients, day admitted patients or patients on discharge:
These Arrangements commence on 1 May 2007.
The Arrangements under subparagraph 100(1)(b)(i) of the National Health Act 1953 made on
12 March 2007 with effect from 1 April 2007 (No. PB 25 of 2007) are, in these Arrangements, referred to as the Principal Arrangements.
Schedule 2 to the Principal Arrangements is amended by adding the following details in respect of the pharmaceutical benefit Apomorphine Hydrochloride:
Column 1 Column 2 Column 3 Column 4 Name of highly specialised drug Form (strength, type, size etc.) Manner of administration Brand Injection 20 mg in 2 mL Injection MX
Dated this 30 day of March 2007.
STEPHEN DELLAR
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Delegate of the Minister for Health and Ageing
0
0
0